Genotyping & Gene Expression
Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Bibby Scientific Announces Stuart® Flexi Block Accessories
Wednesday, March 18, 2015
New accessories offer analytical and life scientists a revolutionary way to heat samples of any size.
Bio-Rad Adds New PrimePCR™ Products for Droplet Digital™ PCR (ddPCR™)
Monday, March 02, 2015
The release expands Bio-Rad’s offering of predesigned validated copy number assays to a total of 658 targets.
The Array Tape Platform Delivers the Next Evolution of PCR Instrumentation
Monday, February 09, 2015
Douglas Scientific® LLC announces the launch of IntelliQube®, the next generation of high throughput qPCR in Array Tape®.
TAdvanced Thermal Cycler with Silver Block
Saturday, January 31, 2015
Highest speed and reproducibility for ultimate PCR performance.
Shimadzu Launches Nexera UC
Thursday, January 29, 2015
Nexera Unified Chromatography system showcases complete automation and combines automatic sample pre-treatment with chromatographic separation and analysis.
UK Biobank Selects Trinean’s DropSense96™
Wednesday, January 14, 2015
DropSense96™ droplet reader selected for DNA quantitation throughout its Genotyping project.
Affymetrix Expands Portfolio of Axiom Genotyping Arrays for Agrigenomics
Sunday, January 11, 2015
New offerings for porcine and equine studies.
Exiqon Launches Two New Research Use Only Kits
Friday, December 19, 2014
The miRSIGN™ miR-21 Oncogene assay and the miRSIGN™ Colon Cancer assay for PCR analysis of colon cancer samples.
Bio-Rad Introduces Bio-Plex Pro™ Human Inflammation Panels
Tuesday, December 16, 2014
Superior profiling of cancer, cardiovascular, and other disease biomarkers.
Showing Results 61 - 70 of 790
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Scoliosis Linked to Disruptions in Spinal Fluid Flow
A new study in zebrafish suggests that irregular fluid flow through the spinal column brought on by gene mutations is linked to a type of scoliosis that can affect humans during adolescence.
A New Tool Brings Personalized Medicine Closer
Scientists from EPFL and ETHZ have developed a powerful tool for exploring and determining the inherent biological differences between individuals, which overcomes a major hurdle for personalized medicine.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,200+ scientific and medical posters
4,600+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!